160 related articles for article (PubMed ID: 11839593)
1. Quantitative trait loci influence renal disease progression in a mouse model of Alport syndrome.
Andrews KL; Mudd JL; Li C; Miner JH
Am J Pathol; 2002 Feb; 160(2):721-30. PubMed ID: 11839593
[TBL] [Abstract][Full Text] [Related]
2. Genetic reprogramming with stem cells regenerates glomerular epithelial podocytes in Alport syndrome.
LeBleu VS; Kanasaki K; Lovisa S; Alge JL; Kim J; Chen Y; Teng Y; Gerami-Naini B; Sugimoto H; Kato N; Revuelta I; Grau N; Sleeman JP; Taduri G; Kizu A; Rafii S; Hochedlinger K; Quaggin SE; Kalluri R
Life Sci Alliance; 2024 Jun; 7(6):. PubMed ID: 38561223
[TBL] [Abstract][Full Text] [Related]
3. PDGF-D Is Dispensable for the Development and Progression of Murine Alport Syndrome.
Firat EAM; Buhl EM; Bouteldja N; Smeets B; Eriksson U; Boor P; Klinkhammer BM
Am J Pathol; 2024 May; 194(5):641-655. PubMed ID: 38309427
[TBL] [Abstract][Full Text] [Related]
4. Endothelin-1 mediated induction of extracellular matrix genes in strial marginal cells underlies strial pathology in Alport mice.
Meehan DT; Delimont D; Dufek B; Zallocchi M; Phillips G; Gratton MA; Cosgrove D
Hear Res; 2016 Nov; 341():100-108. PubMed ID: 27553900
[TBL] [Abstract][Full Text] [Related]
5. Glomerular basement membrane and related glomerular disease.
Chen YM; Miner JH
Transl Res; 2012 Oct; 160(4):291-7. PubMed ID: 22683419
[TBL] [Abstract][Full Text] [Related]
6. Biophysical properties of normal and diseased renal glomeruli.
Wyss HM; Henderson JM; Byfield FJ; Bruggeman LA; Ding Y; Huang C; Suh JH; Franke T; Mele E; Pollak MR; Miner JH; Janmey PA; Weitz DA; Miller RT
Am J Physiol Cell Physiol; 2011 Mar; 300(3):C397-405. PubMed ID: 21123730
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneous stock rats: a new model to study the genetics of renal phenotypes.
Solberg Woods LC; Stelloh C; Regner KR; Schwabe T; Eisenhauer J; Garrett MR
Am J Physiol Renal Physiol; 2010 Jun; 298(6):F1484-91. PubMed ID: 20219828
[TBL] [Abstract][Full Text] [Related]
8. Tauroursodeoxycholic acid ameliorates renal injury induced by COL4A3 mutation.
Yu S; Gu X; Zheng Q; Liu Y; Suhas T; Du W; Xie L; Fang Z; Zhao Y; Yang M; Xu J; Wang Y; Lin MH; Pan X; Miner JH; Jin Y; Xie J
Kidney Int; 2024 May; ():. PubMed ID: 38782199
[TBL] [Abstract][Full Text] [Related]
9. A comparative scRNAseq data analysis to match mouse models with human kidney disease at the molecular level.
Abdank K; Cetin SZ; Abedini A; Susztak K; Eckardt KU; Balzer MS
Nephrol Dial Transplant; 2024 May; 39(6):1044-1047. PubMed ID: 38323426
[No Abstract] [Full Text] [Related]
10. Collagen COL4A3 knockout: a mouse model for autosomal Alport syndrome.
Cosgrove D; Meehan DT; Grunkemeyer JA; Kornak JM; Sayers R; Hunter WJ; Samuelson GC
Genes Dev; 1996 Dec; 10(23):2981-92. PubMed ID: 8956999
[TBL] [Abstract][Full Text] [Related]
11. Mouse model of X-linked Alport syndrome.
Rheault MN; Kren SM; Thielen BK; Mesa HA; Crosson JT; Thomas W; Sado Y; Kashtan CE; Segal Y
J Am Soc Nephrol; 2004 Jun; 15(6):1466-74. PubMed ID: 15153557
[TBL] [Abstract][Full Text] [Related]
12. Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome.
Gross O; Beirowski B; Koepke ML; Kuck J; Reiner M; Addicks K; Smyth N; Schulze-Lohoff E; Weber M
Kidney Int; 2003 Feb; 63(2):438-46. PubMed ID: 12631109
[TBL] [Abstract][Full Text] [Related]
13. Molecular and functional defects in kidneys of mice lacking collagen alpha 3(IV): implications for Alport syndrome.
Miner JH; Sanes JR
J Cell Biol; 1996 Dec; 135(5):1403-13. PubMed ID: 8947561
[TBL] [Abstract][Full Text] [Related]
14. Loss of alpha3/alpha4(IV) collagen from the glomerular basement membrane induces a strain-dependent isoform switch to alpha5alpha6(IV) collagen associated with longer renal survival in Col4a3-/- Alport mice.
Kang JS; Wang XP; Miner JH; Morello R; Sado Y; Abrahamson DR; Borza DB
J Am Soc Nephrol; 2006 Jul; 17(7):1962-9. PubMed ID: 16769745
[TBL] [Abstract][Full Text] [Related]
15. Genetic Modifiers of Mendelian Monogenic Collagen IV Nephropathies in Humans and Mice.
Deltas C; Papagregoriou G; Louka SF; Malatras A; Flinter F; Gale DP; Gear S; Gross O; Hoefele J; Lennon R; Miner JH; Renieri A; Savige J; Turner AN
Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761826
[TBL] [Abstract][Full Text] [Related]
16. Recent Advances in Proteinuric Kidney Disease/Nephrotic Syndrome: Lessons from Knockout/Transgenic Mouse Models.
Saiki R; Katayama K; Dohi K
Biomedicines; 2023 Jun; 11(7):. PubMed ID: 37509442
[TBL] [Abstract][Full Text] [Related]
17. Automated recognition of glomerular lesions in the kidneys of mice by using deep learning.
Akatsuka A; Horai Y; Akatsuka A
J Pathol Inform; 2022; 13():100129. PubMed ID: 36268086
[TBL] [Abstract][Full Text] [Related]
18. Genetic background strongly influences the transition to chronic kidney disease of adriamycin nephropathy in mice.
Watanabe M; Hiura K; Sasaki H; Okamura T; Sasaki N
Exp Anim; 2023 Feb; 72(1):47-54. PubMed ID: 36058845
[TBL] [Abstract][Full Text] [Related]
19.
Irion CI; Williams M; Capcha JC; Eisenberg T; Lambert G; Takeuchi LM; Seo G; Yousefi K; Kanashiro-Takeuchi R; Webster KA; Young KC; Hare JM; Shehadeh LA
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743114
[TBL] [Abstract][Full Text] [Related]
20. Tensin 2-deficient nephropathy: mechanosensitive nephropathy, genetic susceptibility.
Sasaki H; Sasaki N
Exp Anim; 2022 Aug; 71(3):252-263. PubMed ID: 35444113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
